Citation only
via OpenAlex
Inhibition of mTOR Signalling: A Potential Anti-aging Drug Strategy
Komal Saraswat, Raushan Kumar, Syed Ibrahim Rizvi
Springer eBooks · 2018 · ▲ 2 citations
Abstract
This 2018 Springer eBook entry examines the inhibition of mTOR(definition) signalling as a theoretical strategy for anti-aging drug development.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1007/978-981-13-1699-9_10
- Canonical
- link ↗
- Fetched
- 2026-10-07 MST
Cite this
APA
Saraswat, K., Kumar, R., & Rizvi, S.I. (2018). Inhibition of mTOR Signalling: A Potential Anti-aging Drug Strategy. <em>Springer eBooks</em>. https://doi.org/10.1007/978-981-13-1699-9_10
Vancouver
Saraswat K, Kumar R, Rizvi SI. Inhibition of mTOR Signalling: A Potential Anti-aging Drug Strategy. Springer eBooks. 2018. doi:10.1007/978-981-13-1699-9_10.
BibTeX
@article{komal2018Inhibi,
title = {Inhibition of mTOR Signalling: A Potential Anti-aging Drug Strategy},
author = {Komal Saraswat and Raushan Kumar and Syed Ibrahim Rizvi},
journal = {Springer eBooks},
year = {2018},
doi = {10.1007/978-981-13-1699-9_10},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Biochemical Society Transactions 2013
Citation only
Adaptation to chronic mTOR inhibition in cancer and in aging
Computational Biology and Chemistry 2026
Citation only
Computational exploration of squalene analog 4,4′diapophytofluene as a potential anti-aging phytotherapeutic
Translational Medicine of Aging 2020
Open access · CC-BY
RTB101 and immune function in the elderly: Interpreting an unsuccessful clinical trial
British Journal of Clinical Pharmacology 2016
Open access · CC-BY
Potential therapeutic effects of the MTOR inhibitors for preventing ageing and progeria‐related disorders
Atherosclerosis 2011
Citation only
Is telomerase a potential target for vascular rejuvenation?
Frontiers in Physiology 2012
Open access · CC-BY